CG

Cai Guo

Principal Scientist - CMC Upstream Development at RemeGen Biosciences

Cai Guo has a diverse work experience in the field of biosciences and research. Their most recent role was as a Principal Scientist - CMC Upstream Development at RemeGen Biosciences, where they provided CMC regulatory strategies and guidance for comparability studies. Prior to that, they worked at Amgen as a Senior Scientist and Scientist in various roles, leading a team and producing therapeutic antibodies. They also conducted cell line development and utilized CRISPR editing tools. Cai Guo started their career as a Postdoctoral Fellow at the California Institute of Technology and City of Hope.

Cai Guo earned a PhD in Biology from the Irell & Manella Graduate School of Biological Sciences from 2003 to 2009. Prior to that, from 1999 to 2003, Cai Guo completed a BS in Biology at Nanjing University.

Location

Ventura, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


RemeGen Biosciences

1 followers

RemeGen is a global biopharmaceutical company, focusing on the discovery, development and commercialization of novel biologics for the treatment of autoimmune, oncology and ophthalmic diseases with significant unmet medical needs. RemeGen Biosciences, a wholly owned subsidiary of RemeGen, is based in South San Francisco, California, the birthplace of biotechnology and in Maryland. Our vision is to create the first-in-class and/or best-in-class biotherapeutics with innovative target discovery strategies, advanced molecule design and protein engineering platforms. Our passion is to serve patients with more effective therapies in a timely manner.